<DOC>
	<DOCNO>NCT00071448</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial determine whether insulin aspart use effectively safely paediatric patient .</brief_summary>
	<brief_title>Insulin Aspart vs. Insulin Lispro v . Regular Insulin Paediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Pediatric patient Type 1 diabetes least one year HbA1c le 12 % Willing administer least 3 injection per day Willing perform self monitor blood glucose ( SMBG ) least 4 time per day , include subject and/or parent/guardian , necessary</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>